The correct Answer is B
The occurrence of agranulocytosis is a hazard of clozapine, but this hazard can be reduced by monitoring the white-cell count. The increasing risk of agranulocytosis with age and the reduced incidence after the first six months of treatment provide additional guidelines for the prescription and monitoring of clozapine treatment in the future. After the FDA approved clozapine, it became available for marketing in the USA in 1990. Potentially fatal agranulocytosis is estimated to occur in 1 to 2 percent of treated patients.
Category:
Psychiatry MCQs
POST COMMENT
0 comments:
Post a Comment